Abstract
This review describes microbial transformation studies of natural drugs, its importance in correlating them with the corresponding metabolism (biotransformation) in animal system and in the structural modification of complex drug molecules, which are difficult to obtain synthetically. Emphasis is laid on the potential microorganisms, which mimic the pathways of mammalian metabolism and which involve in stereoselective, regiospecific and selective conversions of natural drugs to their derivatives by microorganisms, which are more useful and difficult to synthesize. This paper describes the present state-of-art, will elucidate the additional possibilities with microbial biotransformation of natural drugs, i.e., comparison of microbial transformation with mammalian metabolism and possibility of producing novel molecules, which are difficult to produce by other means.
Keywords: biotransformation, microorganisms, microbial metabolites, mammalian metabolites, stereoselective conversion, regiospecific conversion
Current Pharmaceutical Biotechnology
Title: Application of Microbial Biotransformation for the New Drug Discovery Using Natural Drugs as Substrates
Volume: 4 Issue: 3
Author(s): R. K. Venisetty and V. Ciddi
Affiliation:
Keywords: biotransformation, microorganisms, microbial metabolites, mammalian metabolites, stereoselective conversion, regiospecific conversion
Abstract: This review describes microbial transformation studies of natural drugs, its importance in correlating them with the corresponding metabolism (biotransformation) in animal system and in the structural modification of complex drug molecules, which are difficult to obtain synthetically. Emphasis is laid on the potential microorganisms, which mimic the pathways of mammalian metabolism and which involve in stereoselective, regiospecific and selective conversions of natural drugs to their derivatives by microorganisms, which are more useful and difficult to synthesize. This paper describes the present state-of-art, will elucidate the additional possibilities with microbial biotransformation of natural drugs, i.e., comparison of microbial transformation with mammalian metabolism and possibility of producing novel molecules, which are difficult to produce by other means.
Export Options
About this article
Cite this article as:
Venisetty K. R. and Ciddi V., Application of Microbial Biotransformation for the New Drug Discovery Using Natural Drugs as Substrates, Current Pharmaceutical Biotechnology 2003; 4 (3) . https://dx.doi.org/10.2174/1389201033489847
DOI https://dx.doi.org/10.2174/1389201033489847 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Effects of Dietary Polyunsaturated Fatty Acids on Mitochondria
Current Pharmaceutical Design G Protein β γ Subunits as Targets for Small Molecule Therapeutic Development
Combinatorial Chemistry & High Throughput Screening Pharmacological Treatments for Obesity-Related Hypertension
Current Hypertension Reviews Nerve Growth Factor: Early Studies and Recent Clinical Trials
Current Neuropharmacology Modified-Release Solid Formulations for Colonic Delivery
Recent Patents on Drug Delivery & Formulation Effects of Remifentanil on the Cardiac Conduction System. Our Experience in the Study of Remifentanil Electrophysiological Properties
Current Pharmaceutical Design Vitamin D-RAAS Connection: An Integrative Standpoint into Cardiovascular and Neuroinflammatory Disorders
Current Protein & Peptide Science Oxidative Stress on Progenitor and Stem Cells in Cardiovascular Diseases
Current Pharmaceutical Biotechnology Garlic for Cardiovascular Disease: Prevention or Treatment?
Current Pharmaceutical Design Alzheimer’s Disease And Type 2 Diabetes: Exploring The Association To Obesity And Tyrosine Hydroxylase
CNS & Neurological Disorders - Drug Targets Regulation of Adrenomedullin and its Family Peptide by RAMP System – Lessons from Genetically Engineered Mice
Current Protein & Peptide Science Circulating Levels of Uric Acid and Risk for Metabolic Syndrome
Current Diabetes Reviews NFAT Gene Family in Inflammation and Cancer
Current Molecular Medicine Heat Shock Protein Inhibitors for the Treatment of Fungal Infections
Recent Patents on Anti-Infective Drug Discovery Depression and Medication Adherence in Patients on Hemodialysis
Current Hypertension Reviews Spinophilin: A New Tumor Suppressor at 17q21
Current Molecular Medicine Standards and Novel Therapeutic Options in the Treatment of Patients with Soft Tissue Sarcoma
Reviews on Recent Clinical Trials Hormone Replacement Therapy and Stroke
Current Vascular Pharmacology Is Atherothromboaspiration a Possible Solution for the Prevention of No-Reflow Phenomenon in Acute Coronary Syndromes? Single Centre Experience and Review of the Literature
Current Vascular Pharmacology A Review on GABA/Glutamate Pathway for Therapeutic Intervention of ASD and ADHD
Current Medicinal Chemistry